Opus Fund

Opus Fund is a New York-based
Opus Fund's mission is to provide grants to those working in supportive environments of Pulmonary Hypertension to supplement the research costs of studies which will lead to future National Institute of Health-funded grants.
Mission
Pulmonary hypertension is a syndrome characterized by elevated blood pressure in the lungs. Unlike systemic hypertension or "high blood pressure," little is known about the causes of pulmonary hypertension. Pulmonary hypertension is progressive, leading to shortness of breath, exercise limitation, and even death. Unfortunately, most forms of pulmonary hypertension have no effective therapies. Lung transplantation is often the only option, but has its own limitations.
Recent discoveries in the pathogenesis, epidemiology, and treatment of pulmonary hypertension have had a major impact on our understanding of the disease and on the treatment of patients. The Opus Fund for the Cure of Pulmonary Hypertension was established in order to support the efforts of young investigators performing research in pulmonary hypertension under the tutelage of established mentors. The mission of this fund is to provide grants to deserving investigators working in supportive environments to supplement the research costs of studies which will lead to future NIH-funded grants.
Steven M. Kawut, MD
Steven M. Kawut is a Herbert Irving Assistant Professor of Clinical Medicine (in Epidemiology) at Columbia University College of Physicians and Surgeons. He received his medical degree from the Yale School of Medicine in 1995. He completed his clinical training in Internal Medicine and Pulmonary and Critical Care Medicine at the Hospital of the University of Pennsylvania. He completed a two year course towards an MS in Clinical Epidemiology at the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. He joined the Columbia faculty in 2001. He holds a joint faculty appointment in the Division of Pulmonary, Allergy, and Critical Care and in the Department of Epidemiology. He sees patients in the Pulmonary Hypertension Center and Lung Transplant Center at Columbia-Presbyterian Hospital. His research interests include the determinants and prediction of outcome for patients with pulmonary arterial hypertension and for patients who are undergoing lung transplantation. Dr. Kawut has received research support from the National Heart, Lung, and Blood Institute and the Office of Clinical Trials at Columbia University. He participates in Resident and Fellow Mentorship programs, is a member of several Departmental and University Committees at Columbia. Dr. Kawut has published and continues to publish numerous articles and is continually invited to lecture on pulmonary hypertension.

Main Menu

See Also

Main Menu